Magenta Therapeutics
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Magenta Therapeutics's balance sheet done over the years? Its assets were worth $146,645,000 last year, which is less than in the previous period. 28% of Magenta Therapeuticsโ€™s total assets is currently financed by debt. Its liabilities reached the amount of $40,687,000, which means an increase by 136% compared compared to last year.

Debt to Assets

Magenta Therapeutics, Inc. (NASDAQ:MGTA): Debt to assets
2016 11342000 2.3M 20.28%
2017 54463000 4.14M 7.61%
2018 157313000 11.66M 7.42%
2019 161514000 20.32M 12.58%
2020 161619000 17.71M 10.96%
2021 189934000 17.26M 9.09%
2022 146645000 40.68M 27.75%

MGTA Balance Sheet (2016 โ€“ 2022)

2022 2021 2020 2019 2018 2017 2016
Assets
Current assets:
Cash and cash equivalents
57.62M131.65M58.15M65.07M58.34M51.40M4.51M
Short term investments
54.41M45.27M90.68M80.65M84.22M00
Net receivables
0000006.25M
Inventory
00000030K
Other current assets
3.56M3.76M2.69M4.11M2.75M936K41K
Total current assets
115.60M176.92M151.52M149.84M145.32M52.50M10.83M
Non-current assets:
Property, Plant and Equipment
29.26M7.46M8.31M9.89M10.21M1.95M508K
Goodwill
0000000
Intangible assets
0000000
Long term investments
0000000
Other non-current assets
1.78M5.54M1.78M1.78M1.78M4K0
Total non-current assets
31.04M13.00M10.09M11.67M11.99M1.96M508K
Total assets
146.64M189.93M161.61M161.51M157.31M54.46M11.34M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
0000000
Short term debt
3.82M000000
Total current liabilities
14.54M10.86M11.43M14.11M10.41M4.14M2.3M
Non-current liabilities:
Long term debt
26.13M000000
Deferred tax
0000000
Other non-current liabilities
06.39M6.28M6.20M1.24M00
Total non-current liabilities
26.13M6.39M6.28M6.20M1.24M00
Total liabilities
40.68M17.26M17.71M20.32M11.66M4.14M2.3M
Data sourceData sourceData sourceData sourceData source